1,5-disubstituted-3,4-dihydro-1H-pyrimi do(4,5-D)pyrimidin-2one compounds and their use in treating CSBP/P38 kinase mediated diseases

Details for Australian Patent Application No. 2001239992 (hide)

Owner SmithKline Beecham Corporation

Inventors Taggart, John J.; Hall, Ralph F.; Boehm, Jeffrey C.; Adams, Jerry L.

Agent Davies Collison Cave

Pub. Number AU-B-2001239992

PCT Pub. Number WO01/64679

Priority 60186419 02.03.00 US

Filing date 2 March 2001

Wipo publication date 12 September 2001

Acceptance publication date 1 September 2005

International Classifications

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 031/519 - ortho- or peri-condensed with heterocyclic rings

Event Publications

1 September 2005 Application Accepted

  Published as AU-B-2001239992

5 January 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001239993

2001239991